Zymo Research Granted CE IVD Mark for Quick SARS-CoV-2 rRT-PCR Kit
PR85194
IRVINE, California, Aug. 20, 2020 /PRNewswire＝KYODO JBN/ --
Zymo Research announced that it was recently granted the CE IVD Mark for its
Quick SARS-CoV-2 rRT-PCR Kit. To obtain this certification the product had to
comply with the Directive 98/79/EC of the European Parliament and of the
Council of 27 October 1998 on in vitro diagnostic medical devices.
Photo - https://mma.prnewswire.com/media/1230773/Zymo_Research_Lab_Kit.jpg
Logo - https://mma.prnewswire.com/media/364743/Zymo_Research_Corp_Logo.jpg
The Quick SARS-CoV-2 rRT-PCR Kit (https://c212.net/c/link/?t=0&l=en&o=2891095-1&h=4118966171&u=https%3A%2F%2Fwww.zymoresearch.com%2Fpages%2Fquick-sars-cov-2-rrt-pcr&a=Quick%C2%A0SARS-CoV-2+rRT-PCR+Kit ) is a real-time reverse
transcription PCR (rRT-PCR) test used for the qualitative detection of nucleic acids
from SARS-CoV-2 in upper and lower respiratory specimens. The test has been
previously authorized by the Food & Drug Administration (FDA) under an emergency
use and it is widely used in the U.S.A. for the diagnosis of COVID-19.
With a limit of detection as low as 15 GEC/reaction (250 GEC/ml of sample) and
a robust control system, this test outperforms most SARS-CoV-2 molecular tests
currently on the market; and unlike many other molecular tests, the Quick
SARS-CoV-2 rRT-PCR Kit includes ready-to-use reaction mixtures reducing
hands-on time and eliminating human errors during the set-up process.
In addition, the test is fast and results are generated in less than 1.5 hours.
Zymo Research can readily scale the production as needed, without the reliance
on other vendors that can influence the supply chain. Millions of tests per day
can be manufactured, as needed, to support the fight against COVID-19.
Moreover, with a worldwide network of distributors, as well as subsidiaries in
Germany and China, Zymo Research is logistically set up to supply the Quick
SARS-CoV-2 rRT-PCR Kit rapidly and efficiently throughout the world. This vast
established distributor network has been instrumental in getting reagents
delivered where they are most urgently needed during this worldwide pandemic.
"Receiving the CE IVD Mark for our Quick SARS-CoV-2 rRT-PCR Kit means we can
better support COVID-19 testing on a global level, something that Zymo Research
has been deeply committed to since the start of the pandemic," said Dr. Paolo
Piatti, Senior Scientist at Zymo Research.
For more information about Zymo Research's Quick SARS-CoV-2 rRT-PCR Kit and
workflow, please visit their website (https://c212.net/c/link/?t=0&l=en&o=2891095-1&h=793486839&u=https%3A%2F%2Fzymoresearch.com%2Fproducts%2Fquick-sars-cov-2-rrt-pcr-kit&a=website ) or contact them via email at covid19requests@zymoresearch.com.
About Zymo Research Corp.
Zymo Research is a privately owned company that has been serving the scientific
and diagnostics community with state-of-the-art molecular biology tools since
1994. "The Beauty of Science is to Make Things Simple" is their motto, which is
reflected in all of their products, from epigenetics to DNA/RNA purification
technologies. Historically recognized as the leader in epigenetics, Zymo
Research is breaking boundaries with novel solutions for sample collection,
microbiomic measurements, diagnostic devices, and NGS technologies that are
high quality and simple to use. Follow Zymo Research on
Facebook (https://c212.net/c/link/?t=0&l=en&o=2891095-1&h=352308865&u=https%3A%2F%2Fwww.facebook.com%2Fzymoresearch&a=Facebook ),
and Instagram (https://c212.net/c/link/?t=0&l=en&o=2891095-1&h=1897675589&u=https%3A%2F%2Fwww.instagram.com%2Fzymoresearch%2F&a=Instagram ).
SOURCE Zymo Research Corp.
CONTACT: Marketing Department, Zymo Research Corp., 949.679.1190,
marketing@zymoresearch.com; Sheila T. Brann, Media Relations, KIWI
Communications, Inc., 714.979.3464, sbrann@kiwi-comm.com
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。
